Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients
Clinical trial NCT03927144 · COMPLETED
Trial details
- NCT number
- NCT03927144
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-15
- Primary completion
- 2021-10-01
- Enrollment
- 621
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.